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Introduction: Patterns of High Healthcare 
Utilization in a Pediatric Population
 Since the passing and implementation of the Affordable Care 
Act (ACA) in 2010, those in the healthcare environment have 
had to re-think the way that care is provided to patients:
 Improve healthcare outcomes AND
 Reduce the cost of healthcare
 Particular focus on specific patient populations, including:
 Children with chronic health conditions
 Children with behavioral health diagnoses
Introduction: Changing Payment Model
 Transitioning away from fee-for-service model to a value-
based care model.
 FFS = healthcare providers reimbursed by payors based on 
the number of and types of procedures and services that 
are provided. 
 VBC = Emphasis on the value of patient care rather than 
the quantity.
Introduction: Affordable Care Act and 
Value Based Care
 VBC = Emphasis on the value of patient care rather than 
the quantity of services provided.
 Manage care proactively
 Care linked to specific goals
 Three main drivers:
 Reduce “unnecessary” healthcare expenditures
 Improve health outcomes and improve quality of care
 Care coordination and population health management
Introduction: Institute for Healthcare 
Improvement - Triple Aim
 The Triple Aim is a framework developed by the Institute for Healthcare 
Improvement (IHI) in 2007 to improve the performance of healthcare 
systems. 
 Consists of driving changes in three interconnected dimensions of the 
healthcare system:
 Improving the patient experience of care
 Improving the health of populations
 Reducing the per capita cost of healthcare
 The IHI proposed the following components as integral to achieving the 
Triple Aim:
 Focus on individuals and families
 Redesign of primary care services and structures
 Population health management
 Cost control platform
 System integration and execution
Introduction: Connection to Triple Aim
 A key aspect of reducing unnecessary or preventable healthcare 
costs and utilization is the identification of patients who are the 
highest or most frequent users of healthcare resources.
 Then identify or develop efforts to reduce unnecessary or preventable 
healthcare utilization
 Aligns with component on redesigning primary care services and 
structures
 At the same time, improve healthcare and healthcare outcomes. 
 Existing studies on high utilization look at patient characteristics 
associated with high utilization of healthcare resources including 
those with chronic conditions and those with behavioral health 
diagnoses. 
Introduction: Patterns of High Healthcare 
Utilization in a Pediatric Population
 High utilizing patients are generally described as patients 
whose healthcare use falls within the top 5-10% of use (Bell, 
Turbow, George, & Ali, 2017; Fondow et al., 2017; Hardy et al., 
2018; Heincelman et al., 2016). 
 Like their adult counterparts, pediatric patients with patterns 
of high healthcare utilization have a considerable impact on the 
pediatric healthcare system (Berry et al., 2017).
 Children with more than one chronic condition are one of the 
fastest growing populations within children’s hospitals over the 
past 10 years (Berry et al., 2017). 
Introduction: Patterns of High Healthcare 
Utilization in a Pediatric Population
 Need to identify and understand pediatric healthcare use, 
especially for high use patients (Leininger et al., 2015).
 BUT, little is known about the various ways that chronic 
conditions affect healthcare utilization for pediatric 
patients. 
Introduction: Behavioral Health
 Individuals with Behavioral Health (BH) diagnoses tend to use more 
healthcare resources than individuals without (Bell et al., 2017).
 BH diagnoses and healthcare use in children is not as well studied as 
in adults. 
 BH diagnoses in children and adolescents can have adverse effect on 
long-term health and development.
 Gaps in understanding the relationship between healthcare 
utilization patterns and behavioral health in a pediatric population 
when comorbidities are taken into consideration. 
 Further research can expand our understanding of how behavioral 
health diagnoses and improving behavioral health management 
impact short-and long-term health.
Purpose of This Study
 Expand upon previous work on high healthcare utilization and 
behavioral health diagnoses in children.
 Investigate the extent to which BH diagnoses and chronic 
conditions are associated with high healthcare use in 
children, and if high healthcare use itself is associated with BH 
or chronic condition diagnoses in children.
 Identify characteristic of pediatric patients with high 
utilization patterns, and develop a model that can be tested to 
predict patients who might have similar patterns in the future.
Conceptual Model
Methodology: Medical Expenditures Panel 
Survey (MEPS)
 3 main components:
 Household Component
 Medical Provider Component
 Insurance Component
 Large-scale population-based surveys of civilian, non-
institutionalized families and individuals, healthcare providers, and 
employers in the United States.
 Administered by the Agency for Healthcare Research and Quality
(AHRQ).
 Captures data over a 2+ year panel period.
 Captures person-level data on medical events, frequency of 
healthcare use, cost of healthcare services, how services are paid for 
and insurance types. 
Methodology: MEPS
 Created in 1996.
 First sampling design used from 1996-2006; second from 2007-
2016; third from 2017-2025.
 Samples subset of individuals and families from the previous 
year’s National Health Interview Survey (NHIS), which is also a 
nationally representative sample of non-institutionalized 
individuals.
 Overlapping panel design: 
 New panel selected each year
 Surveys administered to each panel in 5 rounds of computerized self-
administered surveys over a 30-month period
Methodology: MEPS Panel Design
Methodology: MEPS
 Used frequently to assess patterns of healthcare utilization 
and expenditures.
 Allows for a patient-centered perspective to categorizing 
medical expenditures.
 Used to compare the different types of costs for medical 
expenses and different types of utilization for patient 
populations.
 Also used to assess racial, ethnic and other disparities in 
healthcare utilization.
 There are other topics of study that could benefit from the 
MEPS and its study design. 
Methodology
 Retrospective longitudinal observational study.
 Data from the MEPS Household Component survey for 2007-
2016.
 Full Year Consolidated Data Files and corresponding Medical 
Conditions files were used 




 Age, sex, race, ethnicity, family income (as % of federal poverty 
level), and health insurance type
 Dependent Variables
 Presence or absence of a behavioral health diagnoses
 Presence or absence  of a chronic condition diagnosis (asthma, 
gastrointestinal disorders, diabetes)
 Healthcare utilization – yes or no, top 10% in terms of frequency
 Healthcare costs – yes, no, top 10% in terms of cost




 Descriptive analyses (means, medians, percentages)
 Bivariate analyses – assess differences between pediatric 
patients with/without behavioral diagnoses, and 
with/without chronic conditions, controlling for demographic 
characteristics; tests for significance.
 Multivariate analyses – assess associations between 
independent and dependent variables.
 Analysis done using IBM SPSS Statistics Software Version 26 
Premium Edition, Complex Samples Procedures.
 Analytical weights applied during analysis provided by AHRQ.
Analysis: Significance
 𝝌2 Test
 Calculates p-value, which can be used to determine 
significance
 p ≤ .000
 p ≤ .005
 p ≤ .05
 Confidence Intervals
 Range of acceptable values
Results: Table 1, Descriptive Analysis 
(2007-2016)
 2007-2016 unweighted population, age 0-17: 98,004
 Weighted population: 741 million
 Mean age: 8.6 years
 Predominantly white: 74.8%
 Insured (Private or public): 94.6%
 Poor or Near-poor: 26.2%
Results: Table 2, Overall Utilization 
(2007-2016)
Type of Utilization Mean Median
Total expenditures $3,736 $980
Office-based expenditures $950 $352
Prescription medications $596 $33
Office-based Visits 6.1 3
Prescription medications 5 2
Results: Table 3, Total Population with 
Diagnoses (2007-2016)
Percent of Total Population 
with Disease Diagnoses
% of Pediatric Population in 
MEPS, 2007-2016




Results: Table 4, Population Demographics 
Among Children, with Behavioral Health 
Diagnoses (2007-2016)
Demographic Without BH Diagnosis With BH Diagnosis





Poor/ Near-Poor/ Low-Income 37.1% 42.3%
2007-2011 85.5% 14.5%
2012-2016 81.1% 18.9%
Results: Table 5, Mean and Median 
Utilization, Behavioral Health (2007-2016)
Type of use With BH dx Without BH dx
Mean Median Mean Median
Total expenditures ($) 6,290* 2,545 3,224* 817
Office-based exp ($) 1,741* 670 792* 313
Prescription exp ($) 1,618* 481 391* 22
Office-based visits (#) 12.6* 6 4.8* 3
Prescription meds (#) 12.1* 8 3.6* 1
* p≤ .000
Results: Table 6, Mean and Median Utilization, 
Behavioral Health & Asthma (2007-2016)
Type of use With BH Diagnosis Without BH Diagnosis
With Asthma dx Without Asthma dx With Asthma dx Without Asthma dx
Mean Median Mean Median Mean Median Mean Median
Total exp ($) 8,255*** 3,591 5,757* 2,355 5,501*** 1,514 2,845* 748
Office-based exp ($) 2,068* 860 1,653* 611 1,156* 401 731* 300
Prescription exp ($) 2,190* 1,141 1,463* 345 1,047* 236 282* 15
Office-based visits (#) 15.9* 8 11.7* 6 6.5* 4 4.5* 3
Prescription meds (#) 19.6* 14 10.1* 6 8.5* 5 2.8* 1
*p≤ .000. ***p≤ .05.
Results: Table 7, Mean and Median Utilization, 
Behavioral Health & Diabetes (2007-2016)
Type of use With BH Diagnosis Without BH Diagnosis
With Diabetes dx Without Diabetes dx With Diabetes dx Without Diabetes dx
Mean Median Mean Median Mean Median Mean Median
Total exp ($) 8,623 5,715 6,261* 2,518 17,874 4,630 3,148* 811
Office-based exp ($) 2,106 1,522 1,737* 662 1,906 674 786* 312
Prescription exp ($) 5,330 3,147 1,572* 460 3,641 1,654 374* 22
Office-based visits (#) 18.2** 11 12.5* 6 7.1** 5 4.8* 3
Prescription meds (#) 31.2*** 32 11.9* 7 19.6*** 15 3.5* 1
*p≤ .000. **p≤ .005. ***p≤ .05.
Results: Table 8, Mean and Median Utilization, 
Behavioral Health & GI Diagnoses (2007-2016)
Type of use With BH Diagnosis Without BH Diagnosis
With GI dx Without GI dx With GI dx Without GI dx
Mean Median Mean Median Mean Median Mean Median
Total exp ($) 7,724 3,093 6,112* 2,501 9,677 1,269 2,636* 791
Office-based exp ($) 2,264*** 914 1,677* 638 1,183*** 455 756* 301
Prescription exp ($) 2,600 668 1,496* 466 905 61 344* 20
Office-based visits (#) 15.2* 8 12.3* 6 6.8* 4 4.6* 3
Prescription meds (#) 16* 12 11.6* 7 7.5* 3 3.2* 1
*p≤ .000. **p≤ .005. ***p≤ .05.
Results: Table 9, Mean and Median Utilization, 
Behavioral Health & Before/After ACA









Mean Median Mean Median Mean Median Mean Median
Total exp ($) 4,516* 2,333 7,649** 2,733 2,723* 750 3,750** 898
Office-based exp ($) 1,329* 578 2,057* 767 666* 274 926* 363
Prescription exp ($) 1,273* 526 1,882* 429 310* 23 476* 22
Office-based visits (#) 10.6* 5 14.2* 6 4.5* 3 5.1* 3
Prescription meds (#) 11.1* 7 12.8* 8 3.6* 2 3.5* 1
*p≤ .000. **p≤ .005. ***p≤ .05.
Results: Odds Ratios
 Children with a behavioral health diagnosis were more likely to have 
any healthcare expenditures than children without a BH diagnosis.
 OR, 3.5 (2.8, 4.3)*
 Children with asthma and with a BH diagnosis had higher odds of having 
healthcare expenditures than children with asthma and without a BH 
diagnosis. 
 OR, 2.2 (1.1, 4.5)**
 Children with a GI diagnosis and a BH diagnosis had higher odds of 
having healthcare expenditures compared to children with a GI diagnosis 
and without a BH diagnosis.
 OR, 8.6 (1.1, 66.3)**
 The sample side was too small to provide accurate odds ratios for the odds 
of having healthcare expenditures for children with a diabetes diagnosis 
and a BH diagnosis. 
*p≤ .000. **p≤ .001. 
Results: High Utilizing Children & Odds Ratios
 Children in the top 10th percentile of total healthcare expenditures were more 
likely to have a BH diagnosis than children in the lowest 10th percentile of total 
healthcare expenditures. 
 OR, 8.7 (7.4, 10.2)*
 Children with asthma and in the top 10th percentile of total healthcare 
expenditures were more likely to have a BH diagnosis than children in the lowest 
10th percentile.
 OR, 9.7 (5.8, 16.3)*
 Children with a diabetes diagnosis and in the top 10th percentile of total 
healthcare expenditures were more likely to have a BH diagnosis than children 
in the lowest 10th percentile.
 OR, 4.0 (0.4, 45.2)*
 Children with a GI diagnosis and in the top 10th percentile of total healthcare 
expenditures were more likely to have a BH diagnosis than children in the lowest 
10th percentile.
 OR, 10.1 (4.4, 23.2)*
*p≤ .000. **p≤ .05.
Results: Table 17, High Utilizing 
Children, Mean Healthcare Costs
Mean Total Healthcare Expenditures
Before ACA (2007-2011) After ACA (2012-2016)
Top 10th percentile, 
with BH diagnosis
$1,869 $1,198
Top 10th percentile, 
without BH diagnosis
$1,011 $1,083




 Findings support idea that children with behavioral health 
diagnoses have different, higher mean and median healthcare 
expenditures compared to children without a BH diagnosis. 
 Children with a BH diagnosis had higher odds of using 
healthcare resources than children without.
 Changes in healthcare expenditures and utilization are closely 
linked to office-based visits and prescription medications.
 Healthcare expenditures and utilization increase to different 
degrees with the presence of a BH diagnosis alone, a chronic 
condition alone, or both a BH and a chronic condition.  
 May be useful in predicting which patients may be high utilizing 
patients in the future.
Implications
 ACA increased healthcare access, however the long-term status of 
ACA and its impact on the healthcare system in the United States is 
still unknown. 
 Value Based Care model may continue to drive changes in how care is 
provided.
 Insert case manager for children with BH diagnoses and a comorbid 
chronic condition 
 Develop interventions; co-locating specialty care and behavioral health
 Further research should examine healthcare cost and utilization 
based on order of diagnoses.
 Healthcare resources are finite; need to think creatively about how 
to provide ideal care to as many patients as possible.
 Possibly use this type of analysis for predictive analytics/ EMR 
integration.
Future Areas of Study
 Healthcare utilization for multiple complex children 
within a single household.
 BH diagnoses and number of chronic conditions.
 Consider differences in utilization by types of BH 
diagnosis.
 Further investigation into why mean total expenditures 
for children with diabetes alone is higher than for children 
with a BH diagnosis and diabetes.
 Investigation of utilization outcomes for different types of 
interventions (care coordination, care management, co-
location/integration of services, etc.).
Future Areas of Study, cont’d.
 Impact of parent/caregiver/family characteristics and 
diagnoses on child healthcare utilization.
 Look at utilization for individual children longitudinally.
 Look at healthcare utilization through lens of clinical 
guidelines for care. 
 Evaluate healthcare cost and utilization based on 
participant perceptions of healthcare access. 
Limitations
 MEPS does not distinguish between prescription fills and 
refills, so not able to determine medication compliance.
 Dataset does not distinguish between types of office-
based visits, such as sick visits or physicals. 
 This study does not suggest causality between BH 
diagnosis, chronic condition, and healthcare utilization. 
 MEPS data is self-reported, so it is subject to reporting 
error.
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